MSB 4.44% $1.40 mesoblast limited

Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-92

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6 Posts.
    lightbulb Created with Sketch. 4
    The PRV (priority review voucher) and accelerated approval will be huge! Very exciting times ahead.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.